Effect of H4R antagonist N-(2-aminoethyl)-5-chloro-1H-indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1H-benzimidazole on histamine and 4-methylhistamine-induced mast cell response

References

• Panettieri RA Jr. Airway smooth muscle: immunomodulatory cells that modulate airway remodelling? Respir Physiol Neurobiol 2003;137:277–93.
   PubMed Web of Science ®Google Scholar
• Umetsu D, McIntire J, Akbari O, et al. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3:715–20.
   PubMed Web of Science ®Google Scholar
• Zhang M, Thurmond RL, Dunford PJ. The histamine H4 receptor: a novel modulator of inflammatory and immune disorders. Pharmacol Ther 2007;113:594–606.
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004;309:404–13.
   PubMed Web of Science ®Google Scholar
• Seifert R, Schneider EH, Dove S, et al. Pardoxical Stimulatory effect of the standard Histamine H4 receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domine receptors exhibiting functional selectivity. J Mol Pharmacol 2011;79:631–8.
   PubMed Web of Science ®Google Scholar
• Oda T, Morikawa N, Saito Y, et al. Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781–6.
   PubMed Web of Science ®Google Scholar
• Liu C, Ma X, Jiang X, et al. Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 2001;59:420–6.
   PubMed Web of Science ®Google Scholar
• Ling P, Ngo K, Nguyen S, et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004;142:161–71.
   PubMed Web of Science ®Google Scholar
• Cowden JM, Riley JP, Ying Ma J, et al. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokine. Respir Res 2010;11:86.
   PubMed Web of Science ®Google Scholar
• Schroeder JT, Macglashan DW Jr, Lichtenstein LM. Human basophils: mediator release and cytokine production. Adv Immunol 2001;77:93–122.
   PubMed Web of Science ®Google Scholar
• Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 2009;157:24–33.
   PubMed Web of Science ®Google Scholar
• Angel Jemima E, Prema A, Berla Thangam E. Functional characterisation of histamine H4 receptor on human mast cells. Mol Immunol 2014;62:19–28.
   PubMed Web of Science ®Google Scholar
• Seifert R, Strasser A, Schneider EH, et al. Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci 2013;34:33–58.
   PubMed Web of Science ®Google Scholar
• Geng S, Gao YD, Yang J, et al. Potential role of store-operated Ca2+ entry in Th2 response induced by histamine in human monocyte-derived dendritic cells. Int J Immunopharmacol 2012;12:358–67.
   Web of Science ®Google Scholar
• Strakhova MI, Cuff CA, Manelli AM, et al. in vitro and in vivo characterization of A-940894: a potent histamine h4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol 2009;157:44–54.
   PubMed Web of Science ®Google Scholar
• Jablonowski JA, Grice CA, Chai W, et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 2003;46:3957–60.
   PubMed Web of Science ®Google Scholar
• Reher TM, Neumann D, Buschauer A, Seifer R. Incomplete activation of human eosinophils via the histamine H4-receptor; evidence for ligand-specific receptor conformations. Biochem Pharmacol 2012;84:192–203.
   PubMed Web of Science ®Google Scholar
• Shin N, Covington M, Bian D, et al. INCB38579, a novel potent histamine H4 receptor small molecule antagonist with anti-inflammatory and anti-pruritic functions. Eur J Pharmacol 2012;675:47–56.
   PubMed Web of Science ®Google Scholar
• Venable JD, Cai H, Chai W, et al. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine H4 antagonists. J Med Chem 2005;48:8289–98.
   PubMed Web of Science ®Google Scholar
• Annan N, Silverman RB. New analogues of N-(2-aminoethyl)-4-chlorobenzamide (RO 16-6491). Some of the most potent monoamine oxidase-B inactivators. J Med Chem 1993;36:3968–70.
   PubMed Web of Science ®Google Scholar
• Engle M, Frohner W, Stroba A, Biondi RM. Preparation of 4-hetrocycyl-3-arylbutanoic acid 3,4-di-aryl butanoic acid 4-hetrocyclyl-3-aryl-2-pentonoic acid, and 3,5-diaryl-2-pentenoic acid derivatives as allosteric protein kinase modulators. Universitaet Des Sarnalandes, Application. WO201004311 A1; Apr-22, 2010.
   Google Scholar
• Christopher F, Berla Thangam E, Xavier M. A bioinformatics search for selective histamine H4 receptor antagonists through structure-based virtual screening strategies. Chem Biol Drug Des 2012;79:749–59.
   PubMed Web of Science ®Google Scholar
• Mowbray CE, Bell SA, Clarke NP, et al. Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. Bioorg Med Chem Lett 2011;21:6596–602.
   PubMed Web of Science ®Google Scholar
• Terzioglu Van Rijn RM, Bakker RA, et al. Synthesis and structure-activity relationships of indole and benzimidazole piperazine as histamine H4 receptor antagonists. Bioorg Med Chem Lett 2004;14:5251–6.
   PubMed Web of Science ®Google Scholar
• Kiss R, Noszál B, Rácz Á, et al. Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor. Eur J Med Chem 2008;43:1059–70.
   PubMed Web of Science ®Google Scholar
• Lane CAL, Hay D, Mowbray CE, et al. Synthesis of novel histamine H4 receptor antagonists. Bioorg Med Chem Lett 2012;22:1156–9.
   PubMed Web of Science ®Google Scholar
• Audaloussi M, Lim HD, Van der Meer T, et al. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787. Bioorg Med Chem Lett 2013;23:2663–70.
   PubMed Web of Science ®Google Scholar
• Więcek M, Kottke T, Ligneau X, et al. N-Alkenyl and cycloalkylcarbamates as dual acting histamine H3 and H4 receptor ligands. Bioorg Med Chem 2011;19:2850–8.
   PubMed Web of Science ®Google Scholar
• Smits RA, Lim HD, Van der Meer T, et al. Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics. Bioorg Med Chem Lett 2012;22:461–7.
   PubMed Web of Science ®Google Scholar
• Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung W-P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003;305:1212–21.
   PubMed Web of Science ®Google Scholar
• Coruzzi G, Adami M, Guaita E, et al. Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 2007;563:240–4.
   PubMed Web of Science ®Google Scholar
• Dunford PJ, O’Donnell N, Riley JP, et al. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 2006;176:7062–70.
   PubMed Web of Science ®Google Scholar
• Cowden JM, Yu F, Banie H, et al. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis 2014;73:600–68.
   PubMed Web of Science ®Google Scholar
• Cowden JM, Yu F, Challapalli M, et al. Antagonism of the histamine 4 receptor reduces LPS-induced TNF production in vivo. Inflamm Res 2013;62:599–607.
   PubMed Web of Science ®Google Scholar
• Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Investig Dermatol 2010;130:1023–33.
   PubMed Web of Science ®Google Scholar
• Beerman SG, Glade S, Jonigk D, et al. Opposite effects of mepramine on JNJ7777120- induced amelioration of experimentally induced asthma in mice in sensitization and provocation. PLoS One 2012;7:e30285.
   PubMed Web of Science ®Google Scholar
• Somma T, Cinci L, Formicola G, et al. A selective antagonist of histamine H4 receptors prevents antigen induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-I. Br J Pharmacol 2013;170:200–13.
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Chen B, Dunford PJ, et al. Clinical and preclinical characterization of the histamine H4 receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 2014;667:383–8.
   Google Scholar
• Thurmond RL, Kazerouni K, Chaplan SR, Greenspan AJ, Peripheral neuronal mechanism of itch: histamine and itch. Itch: mechanisms and treatment. Boca Raton, FL: CRC Press 2014;Chap. 10:143–92.
   Google Scholar
• Rossbach K, Wendorff S, Sander K, et al. Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 2009;18:57–63.
   PubMed Web of Science ®Google Scholar
• Seike M, Furuya K, Omura M, et al. Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 2010;65:319–26.
   PubMed Web of Science ®Google Scholar
• Beaumer W, Stahl J, Sander K, et al. Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol 2011;20:577–81.
   PubMed Web of Science ®Google Scholar
• Suwa E, Yamaura K, Oda M, et al. Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 2011;667:383–8.
   PubMed Web of Science ®Google Scholar
• Matsushita A, Seike M, Okawa H, et al. Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 2012;21:714–15.
   PubMed Web of Science ®Google Scholar
• Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effect in NC/Nga mice. Allergy 2012;67:1014–22.
   PubMed Web of Science ®Google Scholar
• Liu H, Altenbach RJ, Carr TL, et al. Cis-4-(piperazine-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h] quinazoline-2-amine (A-987306), a new H4r antagonist that blocks pain responses against Carrageenan-induced hyperalgesia. J Med Chem 2008;51:7094–8.
   PubMed Web of Science ®Google Scholar
• Cowart MD, Altenbach RJ, Liu H, et al. Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 2008;51:6547–57.
   PubMed Web of Science ®Google Scholar
• Savall BM, Chavez F, Tays K, et al. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. J Med Chem 2014;57:2429–39.
   PubMed Web of Science ®Google Scholar
• Ballerini C, Aldinucci A, Luccarini I, et al. Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 2013;170:67–77.
   PubMed Web of Science ®Google Scholar
• Murata Y, Song M, Kikuchi H, et al. Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J Dermatol 2015;42:129–39.
   PubMed Web of Science ®Google Scholar
• Thurmond RL. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol 2015;6:1–11.
   PubMed Web of Science ®Google Scholar
• Hartwig C, Munder A, Glage S, et al. The histamine H4 receptor (H4R) regulates eosinophilic inflammation in ovalbumin-induced experimental allergic asthma in mice. Eur J Immunol 2015;45:1129–40.
   PubMed Web of Science ®Google Scholar
• Mirzahosseini A, Dalmadi B, Csutora p. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcɛRI upregulation in murine bone marrow-derived mast cells. Cell Immunol 2013;283:38–44.
   PubMed Web of Science ®Google Scholar
• Engelhardt H, de Esch IJP, Kuhn D, et al. Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. Eur J Med Chem 2012;54:660–8.
   PubMed Web of Science ®Google Scholar
• Lim HD, van Rijn RM, Ling P, et al. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 2005;314:1310–21.
   PubMed Web of Science ®Google Scholar
• Remko AB, Stefan BJ, Schoonus, et al. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signalling. Mol Pharmacol 2001;60:1133–42.
   PubMed Web of Science ®Google Scholar
• Gutzmer R, Mommert S, Gschwandtner M, et al. The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 2009;123:619–25.
   PubMed Web of Science ®Google Scholar
• Desai P, Thurmond RL. Histamine H4 receptor activation enhances LPS-induced IL-6 production in mast cells via ERK and PI3K activation. Eur J Immunol 2011;41:1764–73.
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Mushtaq AA, Khairy MA, et al. Regulation of TNF-a and NFj-B activation through the JAK/STAT signalling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation. Immunobiology 2015;220:889–98.
   PubMed Web of Science ®Google Scholar
• Angel Jemima E, Prema A, Berla Thangam E. H4R activation utilizes distinct signalling pathways for the production of RANTES and IL-13 in human mast cells. J Recept Sig Transd 2016. [Epub ahead of print]. doi: 10.1080/10799893.2016.1203938.
   Google Scholar